OXFORD, UK / ACCESSWIRE / January 17, 2020 / IntraBio Inc, a late-stage biopharmaceutical company, is pleased to share that it has completed enrollment for its IB1001-201 Clinical Trial. IB1001-201 investigates N-Acetyl-L-Leucine (IB1001) for both the symptomatic, and...
The House Energy and Commerce Subcommittee on Health held a hearing on cannabis with much of the focus on research, with the Drug Enforcement Administration revealing that it has a cultivation licensing proposal pending before the White House Office of Management and...
CAMBRIDGE, Mass., Jan. 16, 2020 /PRNewswire/ — Neuroptika, a privately held biotechnology company focused on the development of novel regenerative treatments for ophthalmic diseases, today announced that the first patient was enrolled in a Phase 2 clinical trial...
CHAPPAQUA, N.Y., Jan. 16, 2020 /PRNewswire/ — BioTheryX, Inc., a clinical stage biotechnology company creating new classes of compounds based on multi-kinase inhibition and targeted protein degradation, today announced the initiation of patient dosing in its...
Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology business, today announces the publication of a new randomized controlled trial (RCT) which demonstrated that the use of PICO Single Use Negative Pressure Wound Therapy System (sNPWT) significantly...
Email
Text